TCBS:NASDAQTexas Community Bancshares, Inc. Analysis
Data as of 2026-07-18 - not real-time
$17.45
Latest Price
6/10Risk
Risk Level: Medium
Executive Summary
Texas Community Bancshares (TCBS) trades at $17.45, sitting just above its 50‑day SMA (17.23) but below the 20‑day SMA (17.76), indicating a short‑term pull‑back within a broader bullish trend. The RSI of 48 suggests neutral momentum, while the MACD histogram is negative and the signal line is bearish, adding pressure on the near‑term price. Volume has been declining (today’s 955 vs 10‑day average 1,300), which together with a 30‑day volatility of over 31% underscores a fragile liquidity environment. On the valuation side, the stock’s PE of 16.5 is modestly below the industry average of 17.8 and the price‑to‑book of 0.87 is under 1, hinting at a relative discount, yet the DCF‑derived fair value of $14.96 places the current price in the overvalued range. The dividend yield of 1.34% is supported by a low payout ratio of 16.5%, making the dividend appear sustainable despite a cash balance of $16.5 M against $41.6 M of debt. Recent news highlights “record earnings, loan repricing tailwinds and DFW expansion,” which bolster the earnings outlook but may already be priced into the stock. Considering the mix of modest revenue growth (12.1%), solid operating margins (23%) and a small market cap (~$50 M), the stock sits at a crossroads between short‑term technical weakness and longer‑term fundamental steadiness.
In summary, investors should treat TCBS as a borderline overvalued regional bank with a sustainable dividend, elevated volatility, and liquidity constraints. The immediate technical picture leans bearish, but the underlying growth narrative and relative valuation discounts could make it a hold‑to‑buy candidate for patient, dividend‑focused investors.
In summary, investors should treat TCBS as a borderline overvalued regional bank with a sustainable dividend, elevated volatility, and liquidity constraints. The immediate technical picture leans bearish, but the underlying growth narrative and relative valuation discounts could make it a hold‑to‑buy candidate for patient, dividend‑focused investors.
Market Outlook
Short Term
< 1 yearCautious
Model confidence: 7/10
Key Factors
- Bearish MACD histogram and signal line
- Price below 20‑day SMA and decreasing volume
- Proximity to technical support at $17.23
Medium Term
1–3 yearsNeutral
Model confidence: 6/10
Key Factors
- Revenue growth of 12% and solid operating margins
- Dividend yield of 1.34% with low payout ratio
- Relative valuation discount vs industry PE and PB
Long Term
> 3 yearsPositive
Model confidence: 5/10
Key Factors
- Sustainable dividend and strong cash flow generation
- Potential upside if price reverts toward DCF fair value
- Strategic loan repricing tailwinds and DFW market expansion
Key Metrics & Analysis
Financial Health
Revenue Growth12.10%
Profit Margin18.96%
P/E Ratio16.5
ROE5.67%
ROA0.70%
P/B Ratio0.9
Op. Cash Flow$4.5M
Industry P/E17.8
Technical Analysis
TrendBullish
RSI48.0
Support$17.23
Resistance$18.48
MA 20$17.76
MA 50$17.23
MA 200$16.80
MACDBearish
VolumeDecreasing
Fear & Greed Index87.91
Valuation
Fair Value$14.96
GradeOvervalued
TypeBlend
Dividend Yield1.34%
Risk Assessment
Beta-0.14
Volatility31.43%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskHigh
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.